N. Massy

发表

Tendinous disorders attributed to statins: a study on ninety-six spontaneous reports in the period 1990-2005 and review of the literature.

I. Marie, C. Thuillez, C. Noblet, 2008, Arthritis and rheumatism.

Fatal anaphylaxis with neuromuscular blocking agents: a risk factor and management analysis.

P. Demoly, P. Mertes, P. Gillet, 2014, Allergy.

[Recurrent dysphonia: adverse drug reaction of adalimumab?].

S. Gautier, N. Massy, A. Boruchowicz, 2013, Therapie.

From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak.

D. Levy-bruhl, J. Leroy, A. Deghmane, 2011, The Lancet. Infectious diseases.

Angioedema Triggered by Medication Blocking the Renin/Angiotensin System: Retrospective Study Using the French National Pharmacovigilance Database

H. Lévesque, L. Bouillet, I. Boccon‐Gibod, 2015, Journal of Clinical Immunology.

Neurological Adverse Effects Associated with anti-TNF Alpha Antibodies in Pediatric Inflammatory Bowel Diseases.

J. Hugot, G. Durrieu, S. Coopman, 2020, Journal of pediatric gastroenterology and nutrition.

Poly(ADP‐ribose)polymerase inhibitors‐associated myeloid neoplasms: a retrospective study from the French Network of Pharmacovigilance centres

R. Herbrecht, J. Alexandre, M. Lepelley, 2021, British journal of haematology.

First observation of inhibitor development against efmoroctocog alfa in France.

C. Königs, P. Chamouni, P. Billoir, 2021, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[Severe pseudouveitis associated with moxifloxacin therapy].

J. Gueudry, M. Muraine, N. Massy, 2013, Journal francais d'ophtalmologie.

Comprehensive description of adult-onset Still's disease after COVID-19 vaccination

J. Faillie, N. Massy, V. Bres, 2022, Journal of Autoimmunity.

Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data.

Mary E. Wilson, J. E. Staples, E. Hayes, 2012, Vaccine.

COVID-19 et vaccins à adénovirus : expérience française de suivi renforcé de pharmacovigilance

J. Cracowski, K. Masmoudi, M. Lepelley, 2023, Therapies.

[Agranulocytosis related to fluindione: A case report].

H. Lévesque, G. Buchonnet, Y. Benhamou, 2016, La Revue de medecine interne.

Liquid formulation of ifosfamide increased risk of encephalopathy: A case-control study in a pediatric population.

G. Durrieu, F. Bellet, J. Béné, 2019, Therapie.

Deleterious impact of a generic temozolomide formulation compared with brand‐name product on the kinetic of platelet concentration and survival in newly diagnosed glioblastoma

F. Clatot, F. Di Fioré, F. Lamoureux, 2020, Fundamental & clinical pharmacology.

Safety of Cyproheptadine, an Orexigenic Drug. Analysis of the French National Pharmacovigilance Data-Base and Systematic Review

M. Tavolacci, V. Abadie, V. Bertrand, 2021, Frontiers in Pediatrics.

Thromboembolic Events in Women Exposed to Hormonal Contraception or Cyproterone Acetate in 2012: A Cross-Sectional Observational Study in 30 French Public Hospitals

M. Beyens, G. Miremont-Salamé, V. Gras, 2014, Drug Safety.

De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring

G. Moulis, M. Michel, B. Godeau, 2022, Blood.

Neurological Adverse Effects Associated With Anti-tumor Necrosis Factor Alpha Antibodies in Pediatric Inflammatory Bowel Diseases.

J. Hugot, G. Durrieu, S. Coopman, 2020, Journal of pediatric gastroenterology and nutrition.

Complicated atazanavir-associated cholelithiasis: a report of 14 cases.

P. Tattevin, C. Arvieux, E. Polard, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Peripheral neuropathy associated with topical tretinoin therapy

I. Marie, H. Lévesque, N. Massy, 2009, Internal medicine journal.

French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge

A. Pariente, J. Micallef, F. Salvo, 2021, Therapies.

Monitoring the safety of drugs and COVID-19 vaccines by the French Pharmacovigilance Centers during the pandemic: a win-win bet with Health Authorities!

J. Micallef, M. Drici, N. Massy, 2023, Therapies.

Atypical thrombosis associated with VaxZevria® (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres

J. Albucher, A. Pariente, F. Montastruc, 2021, Therapies.

Angioedema Triggered by Medication Blocking the Renin/Angiotensin System: Retrospective Study Using the French National Pharmacovigilance Database

H. Lévesque, L. Bouillet, Y. Benhamou, 2015, Journal of Clinical Immunology.

Neutropénie fébrile : attention au Previscan®

H. Levesque, N. Massy, S. Ngo, 2014 .

[Sarcoïdosis and anti-TNF: a paradoxical class effect? Analysis of the French Pharmacovigilance system database and literature review].

M. Andréjak, P. Gillet, J. Scala-Bertola, 2011, Therapie.

First case of drug rash eosinophilia and systemic symptoms due to boceprevir.

P. Courville, G. Riachi, P. Joly, 2014, Journal of hepatology.

Benzylthiouracil-induced ANCA-associated Vasculitis: A Case Report and Literature Review

J. Doucet, N. Massy, A. Proux, 2019, European Journal of Case Reports in Internal Medicine.

Immune thrombocytopenia following ChAdOx1 vaccine and positive rechallenge with BNT162b2 vaccine: A case report with pharmacovigilance analysis

H. Bagheri, J. Treluyer, A. Régent, 2022, Therapies.